Blink Eye Drops: Bausch + Lomb Continues Deal Streak With $106M Acquisition of J&J Eye Drops
Bausch + Lomb is acquiring Johnson & Johnson's Blink line of eye drops. The deal comes as J&J exits the consumer business while Bausch + Lomb expands its product portfolio with its second deal in as many weeks.
Read full article »
CEO
Blink is a California-based company that manufactures and markets products such as eye drops, eyelid wipes, and oil supplements for the treatment of dry eye diseases.
Read more